about
Development and characterization of mucoadhesive in situ nasal gel of midazolam prepared with Ficus carica mucilage.Pharmacologic management of convulsive status epilepticus in childhood.Significant hypotension following buccal midazolam administration.Management of prolonged seizures and status epilepticus in childhood: a systematic review.Intranasal midazolam compared with intravenous diazepam in patients suffering from acute seizure: a randomized clinical trial.Buccal midazolam for pediatric convulsive seizures: efficacy, safety, and patient acceptability.Community use of intranasal midazolam for managing prolonged seizures.Treatment of community-onset, childhood convulsive status epilepticus: a prospective, population-based study.Who is at risk for prolonged seizures?Intranasal delivery of antiepileptic medications for treatment of seizures.Oromucosal midazolam: a review of its use in pediatric patients with prolonged acute convulsive seizures.Recent advances in febrile seizures.Exploring carer perceptions of training in out-of-hospital use of buccal midazolam for emergency management of seizures (2008-2012).A Common Reference-Based Indirect Comparison Meta-Analysis of Buccal versus Intranasal Midazolam for Early Status Epilepticus.Dosing feasibility and tolerability of intranasal diazepam in adults with epilepsy.Buccal midazolam: is a test dose in hospital needed?Use of intranasal midazolam to treat acute seizures in paediatric community settings.The cost effectiveness of licensed oromucosal midazolam (Buccolam(®)) for the treatment of children experiencing acute epileptic seizures: an approach when trial evidence is limited.Pharmacokinetics and pharmacodynamics of a new highly concentrated intranasal midazolam formulation for conscious sedation.Carers' express positive views on the acceptability, efficacy and safety of buccal midazolam for paediatric status epilepticus.Midazolam vs diazepam in prolonged seizures in children: A pharmacoeconomic approach.Buccal midazolam or rectal diazepam for treatment of residential adult patients with serial seizures or status epilepticus.Convulsive status epilepticus: clinical profile in a developing country.
P2860
Q34280244-10977BD8-133E-416A-BA0E-AC5C36F18E8AQ34465801-5F3EDB0B-41C9-46A3-841F-90EA08438502Q34533566-DC073D44-4174-48F2-805C-F787B2511451Q34971485-6D7C2368-DD1B-440D-BF68-550D1930C225Q36250761-CCA2B232-8F2A-4F68-B058-2084A17D4FB1Q36538823-6B3D3827-F063-4747-A2D3-966973DDD2DAQ36586092-FB534A9F-77A6-4B21-870F-DDC942E80384Q36772387-A715456D-8499-4F38-AE16-7C4C85A52CF2Q36906474-563DD0B6-2C9A-4092-8F15-6967AD9A08EDQ37427001-6DB5BD48-1CCF-4484-BDC2-39AFCA954ECFQ38019029-7358687D-4E2F-499A-8092-5B58B1B75E3BQ38237888-9D68977F-A924-428B-95C3-010E1756F21AQ38320527-F3DA6D9F-AE99-4368-9689-DA88F5E524E8Q38570640-CCAD90EB-01EB-4220-916C-F5595D220DEFQ42678786-49996D1A-20A5-440F-84A6-E7AC439548F5Q42723311-700BA2C4-8F5C-4205-B994-78F5246B32F9Q45058801-2C356AE3-465C-47C8-B0D9-BC2A86E5E173Q45190762-FFB019E2-8325-47D2-9749-BEFDBAAC6278Q47373267-6209A944-663B-44E5-A970-C10A9DE753ECQ47943375-079F5D13-B7F6-4281-9DE4-F6C4D5D5F9BCQ48029900-D57D1FFB-1BE9-4922-8A6E-F663DA78F627Q48298181-780C48FF-E9B3-46D8-88A6-6D8BF2D50CD3Q51744996-77DD3CA9-1BFF-44E9-B919-1D13BC4778B0
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Nasal/buccal midazolam use in the community.
@en
type
label
Nasal/buccal midazolam use in the community.
@en
prefLabel
Nasal/buccal midazolam use in the community.
@en
P2093
P356
P1476
Nasal/buccal midazolam use in the community.
@en
P2093
P356
10.1136/ADC.2002.019836
P407
P577
2004-01-01T00:00:00Z